These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 9744313)
1. Differentiation and programmed cell death-related intermediate biomarkers for the development of non-small cell lung cancer: a pilot study. Zhang H; Yousem SA; Franklin WA; Elder E; Landreneau R; Ferson P; Keenan R; Whiteside T; Levitt ML Hum Pathol; 1998 Sep; 29(9):965-71. PubMed ID: 9744313 [TBL] [Abstract][Full Text] [Related]
2. Induction of squamous differentiation by interferon beta in a human non-small-cell lung cancer cell line. Nair S; Mayotte J; Lokshin A; Levitt M J Natl Cancer Inst; 1994 Mar; 86(5):378-83. PubMed ID: 7905929 [TBL] [Abstract][Full Text] [Related]
3. Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines. Levitt ML; Gazdar AF; Oie HK; Schuller H; Thacher SM Cancer Res; 1990 Jan; 50(1):120-8. PubMed ID: 1967140 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of interferon beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines. Lokshin A; Mayotte JE; Levitt ML J Natl Cancer Inst; 1995 Feb; 87(3):206-12. PubMed ID: 7707408 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancers. Hanaoka T; Nakayama J; Haniuda M; Sato TA Int J Clin Oncol; 2002 Jun; 7(3):152-8. PubMed ID: 12109516 [TBL] [Abstract][Full Text] [Related]
6. Induction of multiple programmed cell death pathways by IFN-beta in human non-small-cell lung cancer cell lines. Zhang H; Koty PP; Mayotte J; Levitt ML Exp Cell Res; 1999 Feb; 247(1):133-41. PubMed ID: 10047455 [TBL] [Abstract][Full Text] [Related]
8. bcl-2 protein in non-small-cell lung carcinoma. Pezzella F; Turley H; Kuzu I; Tungekar MF; Dunnill MS; Pierce CB; Harris A; Gatter KC; Mason DY N Engl J Med; 1993 Sep; 329(10):690-4. PubMed ID: 8393963 [TBL] [Abstract][Full Text] [Related]
9. High prevalence of bcl-2 oncoprotein expression in small cell lung cancer. Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R Anticancer Res; 1995; 15(2):503-5. PubMed ID: 7763030 [TBL] [Abstract][Full Text] [Related]
11. The expression of Bcl-2 family proteins differs between nonsmall cell lung carcinoma subtypes. Berrieman HK; Smith L; O'Kane SL; Campbell A; Lind MJ; Cawkwell L Cancer; 2005 Apr; 103(7):1415-9. PubMed ID: 15700269 [TBL] [Abstract][Full Text] [Related]
12. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation. Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138 [TBL] [Abstract][Full Text] [Related]
13. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766 [TBL] [Abstract][Full Text] [Related]
14. Expression of Ki-67, Bcl-2, Survivin and p53 Proteins in Patients with Pulmonary Carcinoma. Halasova E; Adamkov M; Matakova T; Vybohova D; Antosova M; Janickova M; Singliar A; Dobrota D; Jakusova V Adv Exp Med Biol; 2013; 756():15-21. PubMed ID: 22836614 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer. Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980 [TBL] [Abstract][Full Text] [Related]
16. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis. Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752 [TBL] [Abstract][Full Text] [Related]
18. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors. Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143 [TBL] [Abstract][Full Text] [Related]
19. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014). Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638 [TBL] [Abstract][Full Text] [Related]
20. Bcl-2 protein expression correlates with nodal status in non small cell lung cancer. Groeger AM; Caputi M; Esposito V; De Luca A; Salat A; Murabito M; Giordano GG; Baldi F; Giordano A; Wolner E Anticancer Res; 1999; 19(1B):821-4. PubMed ID: 10216499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]